IRIS - Res&Arch Institutional Research Information System - Research & Archive

FIORETTI, Maria Cristina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.175
EU - Europa 2.423
AS - Asia 1.871
SA - Sud America 388
AF - Africa 37
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
Totale 7.900
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.122
SG - Singapore 904
UA - Ucraina 585
IE - Irlanda 439
BR - Brasile 329
SE - Svezia 326
CN - Cina 283
HK - Hong Kong 281
IT - Italia 241
RU - Federazione Russa 228
DE - Germania 216
VN - Vietnam 207
FI - Finlandia 149
KR - Corea 73
GB - Regno Unito 59
FR - Francia 48
AR - Argentina 25
PL - Polonia 25
IN - India 24
CZ - Repubblica Ceca 22
MX - Messico 22
CA - Canada 19
BD - Bangladesh 16
CH - Svizzera 16
TR - Turchia 16
BE - Belgio 14
AT - Austria 13
NL - Olanda 12
EC - Ecuador 11
GR - Grecia 11
JP - Giappone 11
UZ - Uzbekistan 11
ZA - Sudafrica 11
CI - Costa d'Avorio 10
ES - Italia 8
LB - Libano 8
IQ - Iraq 7
PK - Pakistan 7
PE - Perù 6
CO - Colombia 5
JO - Giordania 5
IL - Israele 4
LT - Lituania 4
CL - Cile 3
EU - Europa 3
KE - Kenya 3
PA - Panama 3
VE - Venezuela 3
BO - Bolivia 2
CR - Costa Rica 2
EG - Egitto 2
ID - Indonesia 2
JM - Giamaica 2
LC - Santa Lucia 2
NG - Nigeria 2
PS - Palestinian Territory 2
PT - Portogallo 2
PY - Paraguay 2
SA - Arabia Saudita 2
TN - Tunisia 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
AU - Australia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
CV - Capo Verde 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GA - Gabon 1
HN - Honduras 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LV - Lettonia 1
MA - Marocco 1
ML - Mali 1
MN - Mongolia 1
MW - Malawi 1
NC - Nuova Caledonia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 7.900
Salva come PNG Salva come JPEG
Città #
Singapore 554
Chandler 494
Dublin 439
Hong Kong 281
San Mateo 271
Jacksonville 251
Boardman 165
Santa Clara 131
Dong Ket 116
Altamura 114
Medford 108
Princeton 108
Des Moines 102
Ashburn 94
Wilmington 92
Lawrence 86
Beijing 74
Ann Arbor 72
Perugia 69
Seoul 69
Munich 67
Andover 62
Moscow 61
Falls Church 47
New York 42
São Paulo 39
Saint Petersburg 36
Ho Chi Minh City 31
Los Angeles 30
Turku 28
Norwalk 27
Dearborn 25
Piscataway 24
The Dalles 23
Woodbridge 23
San Paolo di Civitate 19
Brooklyn 17
Hanoi 17
Dallas 16
Warsaw 15
Brussels 14
Brno 13
Helsinki 13
Shanghai 13
Chicago 11
Abidjan 10
Chennai 10
Nuremberg 10
Boston 9
Fremont 9
Tokyo 9
Columbus 8
Denver 8
Frankfurt am Main 8
Houston 8
Johannesburg 8
Milan 8
Atlanta 7
Cambridge 7
Fortaleza 7
London 7
Orem 7
Rio de Janeiro 7
Ankara 6
Den Haag 6
Jinan 6
Mexico City 6
Montreal 6
Olomouc 6
Poplar 6
Auburn Hills 5
Belo Horizonte 5
Brasília 5
Falkenstein 5
Guayaquil 5
Haiphong 5
Hefei 5
Izmir 5
Lausanne 5
Nanjing 5
Phoenix 5
San Jose 5
Amman 4
Bauru 4
Biên Hòa 4
Campinas 4
Charlotte 4
Frankfurt Am Main 4
Goiânia 4
Lima 4
Maceió 4
Nagpur 4
Querétaro 4
Ribeirão Preto 4
San Diego 4
San Francisco 4
Secaucus 4
Toronto 4
Betim 3
Buenos Aires 3
Totale 4.722
Salva come PNG Salva come JPEG
Nome #
Accelerated hematopoietic recovery and protective effect of the cyclooxygenase inhibitor indomethacin in bacterial infection of neutropenic mice. 135
Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy 133
Cutting edge: Autocrine TGF-beta sustains default tolerogenesis by IDO-competent dendritic cells. 127
T cell apoptosis by kynurenines. 124
A retroviral peptide encoded by mutated env p15E gene is recognized by specific CD8+ T lymphocytes on drug-treated murine mastocytoma P815. 120
CD8+ cell activation to a major mastocytoma rejection antigen, P815AB: requirement for tum- or helper peptides in priming for skin test reactivity to a P815AB-related peptide 117
Immunogenic tumor variants induced by drug treatment of the L5178Y lymphoma: search for serologically defined antigens at the clonal level. 116
IL-12 acts selectively on CD8a- dendritic cells to enhance presentation of a tumor peptide in vivo 106
CD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86. 104
CTLA-4-Ig activates forkhead transcription factors and protects dendritic cells from oxidative stress in nonobese diabetic mice 102
Cell-mediated immunity to chemically xenogenized tumors--IV. Production of lymphokine activity by, and in response to, highly immunogenic cells. 102
Antilymphoma graft responses in the mouse brain: a study of T-dependent functions. 102
Dual effect of IL-4 on resistance to systemic gram-negative infection and production on TNF-alfa 101
3H-aniracetam binds to specific recognition sites in brain membranes 99
Evidence for tumor necrosis factor alpha as a mediator of the toxicity of a cyclooxygenase inhibitor in Gram-negative sepsis. 99
Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells 98
Circulating levels of IL-10 are critically related to growth and rejection patterns of murine mastocytoma cells. 98
Antigenic changes related to drug action. 96
Adoptive immunotherapy of intracerebral murine lymphomas: role of different lymphoid populations. 95
Antitumor activity of three nitrosourea analogues in different experimental tumor system 94
Modulation of tryptophan catabolism by regulatory T cells 93
Autocrine IL-12 is involved in dendritic cell modulation via CD40 ligation 92
A tumor-associated and self antigen peptide presented by dendritic cells may induce T cell anergy in vivo, but IL-12 can prevent or revert the anergic state 91
IL-6 inhibits the tolerogenic function of CD8 alpha+ dendritic cells expressing indoleamine 2,3-dioxygenase. 90
Appearance of strong transplantation antigens in non-immunogenic lymphoma following drug-treatment in vivo. 90
CD40 ligand and CTLA-4 are reciprocally regulated in the Th1 cell proliferative response sustained by CD8+ dendritic cells. 87
Indoleamine 2,3-dioxygenase, transcriptional regulation and autoimmunity. 86
Immunosuppression via tryptophan catabolism: the role of kynurenine pathway enzymes. 86
T-cell subsets, IFN-gamma production and efferent specificity in anti-parental tumor immunity induced by mouse sensitization with xenogenized variant cells. 85
Antigenic properties of lymphoma sublines derived from a drug-treated immunogenic L5178Y leukemia. 85
Enhanced tryptophan catabolism in the absence of the molecular adapter DAP12 84
Cell-mediated immunity to chemically xenogenized tumors. I. Inhibition by specific antisera and H-2 association of the novel antigens. 83
IL-23 neutralization protects mice from Gram-negative endotoxic shock. 81
CD40 ligation prevents onset of tolerogenic properties in human dendritic cells treated with CTLA-4-Ig. 81
Multiple point mutations in an endogenous retroviral gene confer high immunogenicity on a drug-treated murine 80
Dendritic cells, interleukin 12, and CD4+ lymphocytes in the initiation of class I-restricted reactivity to a tumor/self peptide. 80
[In vitro cytolysis mediated by NK effectors: modification of the susceptibility of the target cell by in vivo treatment with DTIC]. 80
Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease 80
Ligand and cytokine dependence of the immunosuppressive pathway of tryptophan catabolism in plasmacytoid dendritic cells. 79
Towards the identification of a tolerogenic signature in IDO-competent dendritic cells 79
Cell-mediated immunity to chemically xenogenized tumors--III. Generation of monoclonal antibodies interfering with reactivity to novel antigens. 79
T cell apoptosis by tryptophan catabolism 78
Murine plasmacytoid dendritic cells initiate the immunosuppressive pathway of tryptophan catabolism in response to CD200 receptor engagement 78
Cutting edge: silencing suppressor of cytokine signaling 3 expression in dendritic cells turns CD28-Ig from immune adjuvant to suppressant. 78
CD40 ligation ablates the tolerogenic potential of lymphoid dendritic cells 78
In vitro generation of primary cytotoxic lymphocytes against L5178Y leukemia antigenically altered by 5-(3,3'-dimethyl-1-triazeno)-imidazole-4-carboxamide in vivo. 77
CTLA-4-Ig regulates tryptophan catabolism in vivo. 76
A defect in tryptophan catabolism impairs tolerance in nonobese diabetic mice 76
IL-9 protects mice from Fram-negative bacterial shock: suppression of alfa-TNF, IL-12 and gamma-IFN, and induction of IL-10. 75
Intrasplenic immunization for the induction of humoral and cell-mediated immunity to nitrocellulose-bound antigen. 75
Use of a skin test assay to determine tumor-specific CD8+ T cell reactivity 74
Functional expression of indoleamine 2,3-dioxygenase by murine CD8 alpha(+) dendritic cells. 74
IL-23 and IL-12 have overlapping but distinct effects on murine dendritic cells. 73
Drug-induced immunogenic changes of murine leukemia cells: dissociation of onset of resistance and emergence of novel immunogenicity. 73
IL-12 induces SDS-stable class II (alpha beta) dimers in murine dendritic cells 72
Identification and immunogenic properties of an 80-kDa surface antigen on a drug-treated tumor variant: relationship to MuLV gp70. 72
Cell-mediated immunity to chemically xenogenized tumors. II. Evidence for accessory function and self-antigen presentation by a highly immunogenic tumor variant. 72
IL-12 ACTS DIRECTLY ON DC TO PROMOTE NUCLEAR LOCALIZATION OF NF-kB AND PRIMES DC FOR IL-12 PRODUCTION 72
Cell-mediated immunity to chemically xenogenized tumors. V. Failure of novel antigens to increase the frequency of tumor-specific cytotoxic T cells. 71
Tryptophan catabolism generates autoimmune-preventive regulatory T cells 70
The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells 70
Kynurenine pathway enzymes in dendritic cells initiate tolerogenesis in the absence of functional IDO. 69
IDO mediates TLR9-driven protection from experimental autoimmune diabetes 69
Functional plasticity of dendritic cell subsets as mediated by CD40 versus B7 activation. 68
Cell-mediated immunity to chemically xenogenized tumors--VI. The effect of cell treatment with retroviral env antisense oligonucleotides. 68
Delayed-type hypersensitivity to tumor antigens co-expressed with immunogenic determinants induced by xenogenization. 68
Systemic adoptive immunotherapy of a highly immunogenic murine lymphoma growing in the brain. 68
IL-12 is both required and sufficient for initiating T-cell reactivity to a class I-restricted tumor peptide (P815AB) following transfer of P815AB-pulsed dendritic cells 68
SOCS3 drives proteasomal degradation of indoleamine 2,3-dioxygenase (IDO) and antagonizes IDO-dependent tolerogenesis 67
Immunogenic properties of retroviral protein p15E from drug-treated murine mastocytoma P815 66
Chemical xenogenization of tumor cells. 65
Immunogenicity of tumor peptides: importance of peptide length and stability of peptide/MHC class II complex 64
Inhibition of murine lymphoma growth by adoptive transfer of lymphocytes sensitized to a xenogenized tumor variant. 64
Endogenous retroviral gp70 genes of the murine lymphoma L5178Y: analysis of restriction fragment polymorphism upon induction of drug-mediated immunogenicity. 64
Rational bases of cancer immunochemotherapy: drug effects on antigen expression 64
Susceptibility of murine lymphoma cells treated with 5-(3,3-dimethyl-1-triazenyl)-1H-imidazole-4-carboxamide to NK-mediated cytotoxicity in vitro. 63
Chemical xenogenization of murine lymphoma cells with triazene derivatives: immunotoxicological studies. 63
Tumor-specific L3T4+ and Lyt-2+ lymphocytes in mice primed to mutagenized cell variants. 62
Cytokines and tumours: problems and perspectives. 62
Changes in the tumorigenic and metastatic properties of murine melanoma cells treated with a triazene derivative. 62
Metabotropic glutamate receptor-4 modulates adaptive immunity and restrains neuroinflammation 61
Immunogenic changes of murine lymphoma cells following in vitro treatment with aryl-triazene derivatives. 61
DNA methylating activity in murine lymphoma cells xenogenized by triazene derivatives. 61
Intrasplenic immunization for the induction of humoral and cell-mediated immunity to nitrocellulose-bound antigen. 61
Cell-mediated immunity to chemically xenogenized tumors. II. Evidence for accessory function and self-antigen presentation by a highly immunogenic tumor variant. 60
Expression of normal histocompatibility antigens in murine lymphomas treated with 5-(3,3'-dimethyl-1-triazeno)-imidazole-4-carboxamide (DTIC) in vivo. 59
Positive regulatory role of IL-12 in macrophages and modulation by IFN-gamma 57
Intracerebral adoptive immunotherapy of a murine lymphoma antigenically altered by drug treatment in vivo. 55
Dendritic cells and interleukin 12 as adjuvants for tumor-specific vaccines. 55
Regulation of tumor antigen expression by drugs acting as mutagens and/or gene activators. 54
Immune system to brain signaling and vice versa: The role of tryptophan and glutamate 53
T-cell subsets, IFN-gamma production and efferent specificity in anti-parental tumor immunity induced by mouse sensitization with xenogenized variant cells. 53
I Chemioterapici 53
O6-methylguanine-DNA methyltransferase activity and induction of novel immunogenicity in murine tumor cells treated with methylating agents. 53
Identification and immunogenic properties of an 80-kDa surface antigen on a drug-treated tumor variant: relationship to MuLV gp70. 52
Induction of tumor suppression and delayed-type footpad reaction by transfer of lymphocytes sensitized to a xenogenized tumor variant. 50
Lack of correlation between DNA-methylating activity and appearance of the immunogenic phenotype in clones of a murine lymphoma treated with mutagens. 50
Molecular and genomic aspects of xenogenizing-alkylating drugs. 49
Rejectionof drug-treated tumor cells inthe peritoneal cavity of mice 48
Tryptophan catabolism in nonobese diabetic mice. 48
Totale 7.760
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.438
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.438
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021490 0 0 0 0 0 67 67 0 111 30 84 131
2021/2022961 15 168 9 56 73 27 16 302 18 29 74 174
2022/20231.664 128 295 15 124 145 247 1 87 556 5 47 14
2023/2024509 44 88 19 6 3 2 108 7 65 8 71 88
2024/20251.357 21 125 77 42 195 61 11 81 265 91 252 136
2025/20261.572 197 258 166 403 354 194 0 0 0 0 0 0
Totale 8.084